Last updated on February 2020

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Brief description of study

The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.

Clinical Study Identifier: NCT03397394

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.